Sulfacetamide/sulfur

Sulfacetamide/sulfur
Combination of
SulfacetamideSulfonamide antibacterial
Sulfur (pharmacy)Keratolytic
Clinical data
AHFS/Drugs.comMultum Consumer Information
License data
Routes of
administration
Topical
Legal status
Legal status
  (verify)

The drug combination sulfacetamide/sulfur is a topical acne medication[1] manufactured by Medicis under the trade name Plexion and also available under other trade names such as Clenia, Prascion, and Avar. It combines sodium sulfacetamide, a sulfonamide antibiotic, and sulfur, a keratolytic agent.[2] It is available in four formulations: as a cleansing cloth, cleanser, topical suspension, and as a facial mask. The sulfacetamide inhibits the growth of the bacterium Cutibacterium acnes that is associated with acne, while sulfur facilitates the removal of dead skin cells to prevent clogged pores.[3]

References

  1. Del Rosso JQ (January 2004). "Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations". Cutis. 73 (1 Suppl): 29–33. PMID 14959943.
  2. "PLEXION (R) (sodium sulfacetamide 10% and sulfur 5%)". Medicis Inc. Retrieved 2008-12-02.
  3. "PLEXION Prescribing information" (PDF). Medicis. Retrieved 2008-12-02.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.